Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -52.0% | +52.5% | 1 / 3 | +28.1% | -9.73 pp | -10.65 pp | +13.9% | 0.00 | 8.46 | 123 | +28,1% | 13,1 | −35,9% | 8.46 | 14.86 | −43,1% |
| Pts | 0 | 12 | 4 | 12 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 17.000 (close price on 2026-10-19)EPS (TTM): 2.009
Financial charts
1.Revenue & growth
VND bn123Q2/26
1.Revenue & growth
VND bn123Q2/26
2.Profit & growth
VND bn13,1Q2/26
3.Profit mix (Penman)
VND bn54,1Q2/26
4.Margins & cost structure
%11.3%Q2/26
5.Returns & cash cycle
% · days14.2%Q2/26
6.Earnings quality & cash
VND bn-0,89Q2/26
7.Asset structure
VND bn1.173Q2/26
8.Funding & debt health
VND bn · times1.173Q2/26
9.Revenue backlog
VND bn785Q2/26
10.Valuation
times · %9,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %557Q2/26
Adjusted EPS growth, latest quarter
-51.8%
Average adjusted EPS growth, 3 quarters
60.5%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
33.0%
Source: vnstockData through Q2/26